Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
To better understand the molecular mechanisms of depression and antidepressant action, we administered chronic social defeat stress followed by chronic imipramine (a tricyclic antidepressant) to mice and studied adaptations at the levels of gene expression and chromatin remodeling of five brain-derived neurotrophic factor (Bdnf) splice variant mRNAs (I-V) and their unique promoters in the hippocampus. Defeat stress induced lasting downregulation of Bdnf transcripts III and IV and robustly increased repressive histone methylation at their corresponding promoters. Chronic imipramine reversed this downregulation and increased histone acetylation at these promoters. This hyperacetylation by chronic imipramine was associated with a selective downregulation of histone deacetylase (Hdac) 5. Furthermore, viral-mediated HDAC5 overexpression in the hippocampus blocked imipramine's ability to reverse depression-like behavior. These experiments underscore an important role for histone remodeling in the pathophysiology and treatment of depression and highlight the therapeutic potential for histone methylation and deacetylation inhibitors in depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“chronic imipramine (a tricyclic antidepressant) administration to mice with chronic social defeat behavior was linked to a selective downregulation of HDAC5 in the hippocampus; viral-mediated HDAC5 overexpression blocked the antidepressant-like effect of imipramine.148”
From Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential (2023) · cites this paper as [148]
In the citing paper
“In the depression mice model, features of abnormal energy metabolism have also been documented, including abnormal glucose metabolism, elevated lactate levels, mitochondrial dysfunction, and abnormal ATP levels [19–22].”
From APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline (2021) · cites this paper as [19]
In the citing paper
“Another attractive feature of this model is that social avoidance induced by 10 d of social defeat can be reversed by chronic, but not acute, antidepressant treatments17,27.”
From A standardized protocol for repeated social defeat stress in mice (2011) · cites this paper as [27]
In the citing paper
“One potential process involved in neuronal loss is decreased brain-derived neurotrophic factor (BDNF) via histone modifications to the promoter region associated with downregulation of BDNF transcripts73, 74.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [74]
In the citing paper
“In particular, antidepressant drugs rapidly activate TrkB signaling and gradually increase BDNF expression, and the behavioral effects of antidepressants are mediated by and dependent on BDNF signaling through TrkB at least in rodents.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [109]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 1×
“In general, histone acetylation (H3 and H4 acetylation) loosens DNA-histone interactions and allows the transcriptional machinery to bind and increase transcriptio”
BackgroundEpigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Self-citationEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Self-citationNibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
High sensitivity mapping of methylated cytosines
Susan, J. C., Harrison, J., Paul, C. L., & Frommer, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.2990 · Cited by 1,862
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Smith, M., Makino, S., Kvetnansky, R., & Post, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,440
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228
Cited by
Items 401–500 of 1,012
Duclot, F., & Kabbaj, M. (2015) · Journal of Experimental Biology · doi:10.1242/jeb.107086 · Cited by 103
Iñiguez, S. D., Vialou, V., Warren, B. L., Cao, J.-L., Alcantara, L. F., Davis, L. C., Manojlovic, Z., Neve, R. L., Russo, S. J., Han, M.-H., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0951-10.2010 · Cited by 103
Self-citationDubey, N., Hoffman, J. F., Schuebel, K., Yuan, Q., Martinez, P. E., Nieman, L. K., Rubinow, D. R., Schmidt, P. J., & Goldman, D. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.229 · Cited by 114
Athira, K. V., Bandopadhyay, S., Samudrala, P. K., Naidu, V. G. M., Lahkar, M., & Chakravarty, S. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191001142934 · Cited by 118
GABAB Receptors and Depression: Current Status
Cryan, J. F., & Slattery, D. A. (2010) · Advances in pharmacology · doi:10.1016/s1054-3589(10)58016-5 · Cited by 111
Neurotrophins: Transcription and Translation
West, A. E., Pruunsild, P., & Timmusk, T. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-45106-5_4 · Cited by 120
Palomer, E., Carretero, J., Benvegnù, S., Dotti, C. G., & Martin, M. G. (2016) · Nature Communications · doi:10.1038/ncomms11081 · Cited by 105
St-Cyr, S., & McGowan, P. O. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00145 · Cited by 102
Epigenetics of major psychosis: progress, problems and perspectives
Labrie, V., Pai, S., & Petronis, A. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.04.002 · Cited by 100
Glover, M. E., & Clinton, S. M. (2016) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2016.04.008 · Cited by 100
Antidepressant-like effects of albiflorin extracted from Radix paeoniae Alba
Wang, Y., Wang, J., Hu, X., Chen, L., Qiu, Z.-K., Zhao, N., Yu, Z.-D., Sun, S.-Z., Xu, Y., Guo, Y., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.029 · Cited by 104
Faster, better, stronger: Towards new antidepressant therapeutic strategies
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 115
The combined effects of exercise and foods in preventing neurological and cognitive disorders
Gomez-Pinilla, F. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.01.023 · Cited by 98
Striatal histone modifications in models of levodopa‐induced dyskinesia
Nicholas, A. P., Lubin, F. D., Hallett, P. J., Vattem, P., Ravenscroft, P., Bezard, E., Zhou, S., Fox, S. H., Brotchie, J. M., Sweatt, J. D., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05417.x · Cited by 100
Seo, M. K., Ly, N. N., Lee, C. H., Cho, H. Y., Choi, C. M., Nhu, L. H., Lee, J. G., Lee, B. J., Kim, G.-M., Yoon, B. J., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.009 · Cited by 116
Epigenetics and depressive disorders: a review of current progress and future directions
Januar, V., Saffery, R., & Ryan, J. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyu273 · Cited by 99
“Increased dimethylation of histone H3 at lysine-27 (H3K27me2) was also observed in response to chronic social defeat, at a global(48) and a gene-specific level at BDNF.(49) Antidepressant use has been associated with different epigenetic modifications, as well as reversing effects observed with chronic defeat stress.”
BackgroundInfluentialProbing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity
Haggarty, S. J., & Tsai, L.-H. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.04.009 · Cited by 100
Neurogenesis and antidepressant action
Park, S. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03043-5 · Cited by 105
Epigenetics in depression and gut-brain axis: A molecular crosstalk
Begum, N., Mandhare, A., Tryphena, K. P., Srivastava, S., Shaikh, M. F., Singh, S. B., & Khatri, D. K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1048333 · Cited by 106
Social stress models in depression research: what do they tell us?
Chaouloff, F. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1606-x · Cited by 123
Goto, T., Kubota, Y., Tanaka, Y., Iio, W., Moriya, N., & Toyoda, A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.040 · Cited by 106
You, C., Zhang, H., Sakharkar, A. J., Teppen, T., & Pandey, S. C. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001144 · Cited by 100
Cognitive Role of Neurogenesis in Depression and Antidepressant Treatment
Perera, T. D., Park, S., & Nemirovskaya, Y. (2008) · The Neuroscientist · doi:10.1177/1073858408317242 · Cited by 101
From synapse to nucleus: Novel targets for treating depression
Covington, H. E., Vialou, V., & Nestler, E. J. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.004 · Cited by 98
Self-citationErnst, C., Chen, E. S., & Turecki, G. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.35 · Cited by 98
Epigenetic Regulation of BDNF Gene in Response to Stress
Fuchikami, M., Yamamoto, S., Morinobu, S., Takei, S., & Yamawaki, S. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.4.251 · Cited by 98
DiNieri, J. A., Nemeth, C. L., Parsegian, A., Carle, T., Gurevich, V. V., Gurevich, E., Neve, R. L., Nestler, E. J., & Carlezon, W. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5104-08.2009 · Cited by 99
Self-citationElsner, V. R., Lovatel, G. A., Bertoldi, K., Vanzella, C., Santos, F. M., Spindler, C. D. F., de Almeida, E. F., Nardin, P., & Siqueira, I. R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.066 · Cited by 110
Mechanisms of Illness Progression in the Recurrent Affective Disorders
Post, R. M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9182-2 · Cited by 111
Antidepressant action of HDAC inhibition in the prefrontal cortex
Covington, H. E., Maze, I., Vialou, V., & Nestler, E. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.030 · Cited by 97
“, imipramine) require 14–20 days for full efficacy (Berton et al., 2006; Tsankova et al., 2006; Covington et al., 2009; Vialou et al., 2010).”
BackgroundResultSelf-citationMouillet‐Richard, S., Baudry, A., Launay, J., & Kellermann, O. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.035 · Cited by 99
Epigenetic Mechanisms: Critical Contributors to Long-Term Memory Formation
Lubin, F. D., Gupta, S., Parrish, R. R., Grissom, N. M., & Davis, R. L. (2011) · The Neuroscientist · doi:10.1177/1073858411386967 · Cited by 80
Chronic Stress and Individual Vulnerability
Schmidt, M. V., Sterlemann, V., & Müller, M. B. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.017 · Cited by 99
Jha, S., Dong, B., & Sakata, K. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.33 · Cited by 98
The prefrontal–limbic network in depression: Modulation by hypothalamus, basal ganglia and midbrain
Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.006 · Cited by 104
Chagnon, Y. C., Potvin, O., Hudon, C., & Préville, M. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00230 · Cited by 97
Delta-Opioid Receptors Are Critical for Tricyclic Antidepressant Treatment of Neuropathic Allodynia
Benbouzid, M., Gavériaux‐Ruff, C., Yalçın, İ., Waltisperger, E., Tessier, L., Muller, A., Kieffer, B. L., Freund‐Mercier, M. J., & Barrot, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.06.016 · Cited by 106
Regulation of the Hypothalamic–Pituitary–Adrenocortical System in Patients with Panic Disorder
Erhardt, A., Ising, M., Unschuld, P. G., Kern, N., Lucae, S., Pütz, B., Uhr, M., Binder, E. B., Holsboer, F., & Keck, M. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301168 · Cited by 116
Jiang, B., Wang, Y., Wang, H., Song, L., Huang, C., Zhu, Q., Wu, F., & Zhang, W. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13668 · Cited by 96
Ehrlich, S., Weiss, D., Burghardt, R., Infante‐Duarte, C., Brockhaus, S., Muschler, M. A. N., Bleich, S., Lehmkuhl, U., & Frieling, H. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.01.011 · Cited by 97
Sex Differences in Stress Response: Classical Mechanisms and Beyond
Hodes, G. E., Bangasser, D. A., Sotiropoulos, I., Kokras, N., & Dalla, C. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231005090134 · Cited by 113
Increased BDNF expression in fetal brain in the valproic acid model of autism
Almeida, L. E. F., Roby, C. D., & Krueger, B. K. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.01.007 · Cited by 97
Subbanna, S., Shivakumar, M., Umapathy, N. S., Saito, M., Mohan, P. S., Kumar, A. R., Nixon, R. A., Verin, A. D., Psychoyos, D., & Basavarajappa, B. S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.022 · Cited by 103
Self-citationLack of promoter IV‐driven BDNF transcription results in depression‐like behavior
Sakata, K., Jin, L., & Jha, S. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00605.x · Cited by 94
Sterrenburg, L., Gaszner, B., Boerrigter, J., Santbergen, L., Bramini, M., Roubos, E. W., Peeters, B. W. M. M., & Kozicz, T. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.22737 · Cited by 95
Ieraci, A., Mallei, A., Musazzi, L., & Popoli, M. (2015) · Hippocampus · doi:10.1002/hipo.22458 · Cited by 94
Aznar, S., & Knudsen, G. M. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100390 · Cited by 94
The Neurobiology of Intervention and Prevention in Early Adversity
Fisher, P. A., Beauchamp, K. G., Roos, L. E., Noll, L. K., Flannery, J., & Delker, B. C. (2016) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032814-112855 · Cited by 94
Epigenetic Determinants of Healthy and Diseased Brain Aging and Cognition
Akbarian, S., Beeri, M. S., & Haroutunian, V. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1459 · Cited by 92
Optogenetic insights into striatal function and behavior
Lenz, J. D., & Lobo, M. K. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.018 · Cited by 99
Cell biology of BDNF and its relevance to schizophrenia
Lu, B., & Martinowich, K. (2008) · Novartis Foundation Symposia · doi:10.1002/9780470751251.ch10 · Cited by 92
O'Sullivan, E., Barrett, E., Grenham, S., Fitzgerald, P., Stanton, C., Ross, R., Quigley, E., Cryan, J., & Dinan, T. (2011) · Beneficial Microbes · doi:10.3920/bm2011.0015 · Cited by 92
Genes, Environment, and Individual Differences in Responding to Treatment for Depression
Uher, R. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.586551 · Cited by 92
Depression and antidepressants: molecular and cellular aspects
Lanni, C., Govoni, S. M., Lucchelli, A., & Boselli, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0055-x · Cited by 107
Serum Response Factor Promotes Resilience to Chronic Social Stress through the Induction of ΔFosB
Vialou, V., Maze, I., Renthal, W., LaPlant, Q. C., Watts, E. L., Mouzon, E., Ghose, S., Tamminga, C. A., & Nestler, E. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2496-10.2010 · Cited by 91
“Data were analyzed by comparing C(t) values of the treatment condition (control vs susceptible or resilient mice, or human controls vs depressed patients) with the C(t) method (Tsankova et al., 2006).”
MethodSelf-citationBoulle, F., Massart, R., Stragier, E., Païzanis, E., Zaidan, L., Marday, S., Gabriel, C., Mocaer, E., Mongeau, R., & Lanfumey, L. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.125 · Cited by 91
ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior
Sun, H., Damez-Werno, D. M., Scobie, K. N., Shao, N.-Y., Dias, C., Rabkin, J., Koo, J. W., Korb, E., Bagot, R. C., Ahn, F. H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3939 · Cited by 91
Self-citationBartlett, A. A., Singh, R., & Hunter, R. G. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-53889-1_8 · Cited by 91
Epigenetics and depression: current challenges and new therapeutic options
Schroeder, M., Krebs, M. O., Bleich, S., & Frieling, H. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833d16c1 · Cited by 90
Gavin, D. P., Kartan, S., Chase, K. A., Jayaraman, S., & Sharma, R. P. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.12.006 · Cited by 93
G9a influences neuronal subtype specification in striatum
Maze, I., Chaudhury, D., Dietz, D. M., Von Schimmelmann, M., Kennedy, P. J., Lobo, M. K., Daws, S. E., Miller, M. L., Bagot, R. C., Sun, H., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3670 · Cited by 92
Self-citationA longitudinal study of BDNF promoter methylation and genotype with poststroke depression
Kim, J., Stewart, R. J., Kang, H., Kim, S., Kim, S., Shin, I., Park, M., Kim, H., Shin, M., Cho, K.-H., et al. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.008 · Cited by 99
Fuzi polysaccharide-1 produces antidepressant-like effects in mice
Yan, H., Qu, H.-D., Sun, L., Li, S.-J., Cao, X., Fang, Y., Jie, W., Bean, J. C., Wu, W.-K., Zhu, X., et al. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990733 · Cited by 92
Chromatin regulation in drug addiction and depression
Renthal, W., & Nestler, E. J. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/wrenthal · Cited by 93
Self-citationEpigenetics of neurobiology and behavior during development and adulthood
Roth, T. L. (2012) · Developmental Psychobiology · doi:10.1002/dev.20550 · Cited by 90
Transgenerational Epigenetic Contributions to Stress Responses: Fact or Fiction?
Nestler, E. J. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002426 · Cited by 105
Self-citationLong-term effects of chronic stress models in adult mice
Tran, I., & Gellner, A. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02598-6 · Cited by 101
LSD1 modulates stress-evoked transcription of immediate early genes and emotional behavior
Rusconi, F., Grillo, B., Ponzoni, L., Bassani, S., Toffolo, E., Paganini, L., Mallei, A., Braida, D., Passafaro, M., Popoli, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511974113 · Cited by 101
Current status and future prospects for epigenetic psychopharmacology
Boks, M. P., de Jong, N. M., Kas, M. J. H., Vinkers, C. H., Fernandes, C., Kahn, R. S., Mill, J., & Ophoff, R. A. (2012) · Epigenetics · doi:10.4161/epi.7.1.18688 · Cited by 89
Jiang, Z., Cowell, R. M., & Nakazawa, K. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00116 · Cited by 99
Qiu, X., Xiao, X., Li, N., & Li, Y. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.002 · Cited by 96
Agis-Balboa, R. C., Guidotti, A., & Pinna, G. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3567-5 · Cited by 89
Greenberg, G. D., Laman-Maharg, A., Campi, K. L., Voigt, H., Orr, V. N., Schaal, L., & Trainor, B. C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00223 · Cited by 89
Bahí, A., Chandrasekar, V., & Dreyer, J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.009 · Cited by 91
Sakharkar, A. J., Zhang, H., Tang, L., Baxstrom, K., Shi, G., Moonat, S., & Pandey, S. C. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000054 · Cited by 88
The epigenetic effects of antidepressant treatment on human prefrontal cortex BDNF expression
Chen, E. S., Ernst, C., & Turecki, G. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001422 · Cited by 88
Meylan, E. M., Halfon, O., Magistretti, P. J., & Cardinaux, J.-R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.012 · Cited by 87
“…evidence both in humans and in animal models have suggested that pathological conditions may alter the expression of Hdac family members, mainly of class I and IIa (Covington et al., 2009; Gräff et al., 2012; Han et al., 2014; Morris and Monteggia, 2013; Tsankova et al., 2006; Uchida et al., 2011).”
InfluentialGlucocorticoid Signaling and Epigenetic Alterations in Stress-Related Disorders
Mourtzi, N., Sertedaki, A., & Charmandari, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115964 · Cited by 86
Modeling treatment-resistant depression
Samuels, B. A., Leonardo, E. D., Gadient, R., Williams, A., Zhou, J., David, D. J., Gardier, A. M., Wong, E. H. F., & Hen, R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.017 · Cited by 87
The effects of olanzapine on genome-wide DNA methylation in the hippocampus and cerebellum
Melka, M. G., Laufer, B. I., McDonald, P., Castellani, C. A., Rajakumar, N., O’Reilly, R., & Singh, S. M. (2014) · Clinical Epigenetics · doi:10.1186/1868-7083-6-1 · Cited by 88
Neuropeptides in depression: Role of VGF
Thakker-Varia, S., & Alder, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.006 · Cited by 86
Ferland, C. L., & Schrader, L. A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.077 · Cited by 85
Benbouzid, M., Choucair‐Jaafar, N., Yalçın, İ., Waltisperger, E., Muller, A., Freund‐Mercier, M. J., & Barrot, M. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.01.010 · Cited by 94
Mechanisms underlying the antidepressant response and treatment resistance
Levinstein, M. R., & Samuels, B. A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00208 · Cited by 99
Nin, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00073 · Cited by 88
Subbanna, S., Nagre, N. N., Shivakumar, M., Umapathy, N. S., Psychoyos, D., & Basavarajappa, B. S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.043 · Cited by 86
The gut virome is associated with stress-induced changes in behaviour and immune responses in mice
Ritz, N. L., Draper, L. A., Bastiaanssen, T. F. S., Turkington, C. J. R., Peterson, V. L., van de Wouw, M., Vlčková, K., Fülling, C., Guzzetta, K. E., Burokas, A., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01564-y · Cited by 93
Kozicz, T., Ouwens, D. T. W. M., Faludi, G., Palkovits, M., & Roubos, E. W. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2007.12.050 · Cited by 93
Duclot, F., & Kabbaj, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0199-13.2013 · Cited by 85
Olsen, C. A., & Ghadiri, M. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900850t · Cited by 84
Epigenetics applied to psychiatry: Clinical opportunities and future challenges
Kular, L., & Kular, S. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12634 · Cited by 79
Circuit-based frameworks of depressive behaviors: The role of reward circuitry and beyond
Knowland, D., & Lim, B. K. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.12.010 · Cited by 86
Progress in Epigenetics of Depression
Peña, C. J., & Nestler, E. J. (2018) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.12.011 · Cited by 84
Self-citationNa, K.-S., Won, E., Kang, J., Chang, H. S., Yoon, H.-K., Tae, W. S., Kim, Y.-K., Lee, M.-S., Joe, S.-H., Kim, H., et al. (2016) · Scientific Reports · doi:10.1038/srep21089 · Cited by 84
The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review
Webb, L. M., Phillips, K. E., Ho, M. C., Veldic, M., & Blacker, C. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030826 · Cited by 84
“DNA methylation has been implicated in psychiatric disorders as a mechanism by which experience alters neuronal gene transcription [31], changing cognitive function and formation of long term memories [32] and emotional processing [33].”
BackgroundHan, X., Tong, J., Zhang, J., Farahvar, A., Wang, E., Yang, J., Samadani, U., Smith, D. H., & Huang, J. H. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2010.1563 · Cited by 85
Gonul, A. S., Kitis, O., Eker, M. C., Eker, O. D., Ozan, E., & Coburn, K. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.507786 · Cited by 84
The GABABreceptor as a target for antidepressant drug action
Ghose, S., Winter, M. K., McCarson, K. E., Tamminga, C. A., & Enna, S. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01004.x · Cited by 86
β2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain
Yalcin, I., Tessier, L.-H., Petit-Demoulière, N., Doridot, S., Hein, L., Freund-Mercier, M.-J., & Barrot, M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.003 · Cited by 84
Mahgoub, M., & Monteggia, L. M. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0213-6 · Cited by 97
Metadata
- Authors
- Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Harvard University (US)
- Corresponding author
- Nestler, Eric J
- Venue
- Nature Neuroscience
- Published
- 2006-02-26
- Volume
- 9
- Issue
- 4
- Pages
- 519-525
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2130685024
- Cited by
- 1,780
- References
- 50
- Citations by year
- 2026: 34 · 2025: 32 · 2024: 52 · 2023: 37 · 2022: 53 · 2021: 73 · 2020: 68 · 2019: 96 · 2018: 81 · 2017: 102 · 2016: 118 · 2015: 106 · 2014: 134 · 2013: 117 · 2012: 146
- FWCI
- 55.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- depression, antidepressant action, chronic social defeat stress, imipramine, hippocampus, chromatin remodeling, histone methylation, histone acetylation, HDAC5, depression-like behavior, histone deacetylase inhibitors
- MeSH terms
- Acetylation, Animals, Antidepressive Agents, Behavior, Animal, Chromatin, Depression, Disease Models, Animal, Hippocampus, Histones, Imipramine, Male, Methylation, Mice, Inbred C57BL, Stress, Psychological, Brain-Derived Neurotrophic Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.